Literature DB >> 2248733

Evidence that cholinergic receptors of muscarinic type may modulate vasopressin release induced by metoclopramide.

L Steardo1, M Iovino, P Monteleone, M Bevilacqua, G Norbiato.   

Abstract

Studies were carried out in the rat in order to investigate whether cholinergic mechanisms may be involved in vasopressin (VP) release induced by metoclopramide (MCP). The intravenous injection of MCP induced dose-related increases in plasma VP levels in water-loaded rats. These effects were prevented by atropine sulphate, but not by pirenzepine hydrochloride indicating that activation of cholinergic receptors of M-2 type was possibly required for the biologic response.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2248733     DOI: 10.1007/bf01272764

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  8 in total

Review 1.  Peripheral receptor populations involved in the regulation of gastrointestinal motility and the pharmacological actions of metoclopramide-like drugs.

Authors:  A G Fernández; R Massingham
Journal:  Life Sci       Date:  1985-01-07       Impact factor: 5.037

2.  Radioimmunoassay of arginine vasopressin in human plasma.

Authors:  M K Husain; N Fernando; M Shapiro; A Kagan; S M Glick
Journal:  J Clin Endocrinol Metab       Date:  1973-10       Impact factor: 5.958

Review 3.  Central nervous system mediators of vasopressin release.

Authors:  A H Sklar; R W Schrier
Journal:  Physiol Rev       Date:  1983-10       Impact factor: 37.312

Review 4.  Two dopamine receptors: biochemistry, physiology and pharmacology.

Authors:  J C Stoof; J W Kebabian
Journal:  Life Sci       Date:  1984-12-03       Impact factor: 5.037

Review 5.  Drug therapy. Metoclopramide.

Authors:  K Schulze-Delrieu
Journal:  N Engl J Med       Date:  1981-07-02       Impact factor: 91.245

6.  Metoclopramide increases vasopressin secretion.

Authors:  G Norbiato; M Bevilacqua; E Chebat; P Bertora; P Cavaiani; C Baruto; S Fumagalli; U Raggi
Journal:  J Clin Endocrinol Metab       Date:  1986-09       Impact factor: 5.958

7.  Effect of substances influencing brain serotonergic transmission on plasma vasopressin levels in the rat.

Authors:  M Iovino; L Steardo
Journal:  Eur J Pharmacol       Date:  1985-07-11       Impact factor: 4.432

8.  Alterations in vasopressin regulation in Alzheimer's disease.

Authors:  G Norbiato; M Bevilacqua; F Carella; E Chebat; U Raggi; P Bertora; M P Grassi; A Mangoni
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-07       Impact factor: 10.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.